Low-dose metformin targets the lysosomal AMPK pathway through PEN2

[1]  B. Viollet,et al.  Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis , 2021, Molecular metabolism.

[2]  O. Werz,et al.  Loss of metabolic plasticity underlies metformin toxicity in aged Caenorhabditis elegans , 2020, Nature Metabolism.

[3]  Sheng-Cai Lin,et al.  Transient Receptor Potential V Channels Are Essential for Glucose Sensing by Aldolase and AMPK , 2019, Cell metabolism.

[4]  B. Viollet,et al.  Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus , 2019, Nature Reviews Endocrinology.

[5]  D. Hardie,et al.  Hierarchical activation of compartmentalized pools of AMPK depends on severity of nutrient or energy stress , 2019, Cell Research.

[6]  S. Greenland,et al.  Scientists rise up against statistical significance , 2019, Nature.

[7]  Kenli Li,et al.  iProX: an integrated proteome resource , 2018, Nucleic Acids Res..

[8]  F. Sicheri,et al.  Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase , 2018, Nature Medicine.

[9]  W. Jia,et al.  AIDA Selectively Mediates Downregulation of Fat Synthesis Enzymes by ERAD to Retard Intestinal Fat Absorption and Prevent Obesity. , 2018, Cell metabolism.

[10]  M. D. de Broe,et al.  Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4 , 2018, Diabetes Care.

[11]  Stephanie S. Lam,et al.  Electron microscopy using the genetically encoded APEX2 tag in cultured mammalian cells , 2017, Nature Protocols.

[12]  M. Erion,et al.  Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy , 2017, Science.

[13]  D. Hardie,et al.  The mechanisms of action of metformin , 2017, Diabetologia.

[14]  Sheng-Cai Lin,et al.  Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK , 2017, Nature.

[15]  D. Hardie,et al.  AMP-Activated Protein Kinase: An Ubiquitous Signaling Pathway With Key Roles in the Cardiovascular System , 2017, Circulation research.

[16]  A. Saghatelian,et al.  Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex. , 2017, Cell metabolism.

[17]  Christopher E. Carr,et al.  An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer , 2016, Cell.

[18]  S. Kritchevsky,et al.  Metformin as a Tool to Target Aging. , 2016, Cell metabolism.

[19]  Yueyao Zhu,et al.  Kinesin 1 Drives Autolysosome Tubulation. , 2016, Developmental cell.

[20]  Robin J. W. Willows,et al.  Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function , 2016, Cell metabolism.

[21]  Antje Bruckbauer,et al.  Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice. , 2015, Metabolism: clinical and experimental.

[22]  A. Ferguson-Smith,et al.  CRISPR-Cas9-Mediated Genetic Screening in Mice with Haploid Embryonic Stem Cells Carrying a Guide RNA Library. , 2015, Cell stem cell.

[23]  G. Rutter,et al.  Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats , 2015, Nature Medicine.

[24]  A. Morris,et al.  Metformin in cancer treatment and prevention. , 2015, Annual review of medicine.

[25]  B. Viollet,et al.  Metformin: from mechanisms of action to therapies. , 2014, Cell metabolism.

[26]  Jiahuai Han,et al.  The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. , 2014, Cell metabolism.

[27]  William B. Mair,et al.  AMPK at the nexus of energetics and aging. , 2014, Cell metabolism.

[28]  R. Cole,et al.  Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)*♦ , 2014, The Journal of Biological Chemistry.

[29]  Michael J. MacDonald,et al.  Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase , 2014, Nature.

[30]  M. Stadecker,et al.  Regulated Assembly of Vacuolar ATPase Is Increased during Cluster Disruption-induced Maturation of Dendritic Cells through a Phosphatidylinositol 3-Kinase/mTOR-dependent Pathway* , 2013, The Journal of Biological Chemistry.

[31]  J. Dyck,et al.  Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin–sensitizing effects of metformin , 2013, Nature Medicine.

[32]  S. Sze,et al.  Design and synthesis of minimalist terminal alkyne-containing diazirine photo-crosslinkers and their incorporation into kinase inhibitors for cell- and tissue-based proteome profiling. , 2013, Angewandte Chemie.

[33]  E. Mercken,et al.  Metformin improves healthspan and lifespan in mice , 2013, Nature Communications.

[34]  B. Viollet,et al.  Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP , 2016 .

[35]  Mark Bates,et al.  Evaluation of fluorophores for optimal performance in localization-based super-resolution imaging , 2011, Nature Methods.

[36]  X. Zhuang,et al.  Fast three-dimensional super-resolution imaging of live cells , 2011, Nature Methods.

[37]  Mengwei Zang,et al.  AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. , 2011, Cell metabolism.

[38]  R. Day,et al.  Clinical Pharmacokinetics of Metformin , 2011, Clinical pharmacokinetics.

[39]  Takanari Inoue,et al.  A photocleavable rapamycin conjugate for spatiotemporal control of small GTPase activity. , 2011, Journal of the American Chemical Society.

[40]  B. Viollet,et al.  Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. , 2010, The Journal of clinical investigation.

[41]  F. Ross,et al.  Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation , 2010, Cell metabolism.

[42]  M. Driscoll,et al.  Metformin Induces a Dietary Restriction–Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1 , 2010, PloS one.

[43]  P. Pinton,et al.  Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells , 2009, Nature Protocols.

[44]  B. Kemp,et al.  AMPK in Health and Disease. , 2009, Physiological reviews.

[45]  J. Leppänen,et al.  The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption. , 2009, Journal of medicinal chemistry.

[46]  F. Wondisford,et al.  Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein , 2009, Cell.

[47]  P. Ward,et al.  Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line , 2007, Diabetologia.

[48]  J. Grieger,et al.  Production and characterization of adeno-associated viral vectors , 2006, Nature Protocols.

[49]  M. Forgac,et al.  Involvement of the Nonhomologous Region of Subunit A of the Yeast V-ATPase in Coupling and in Vivo Dissociation* , 2004, Journal of Biological Chemistry.

[50]  F. Reimann,et al.  A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. , 2003, Diabetes.

[51]  I. Mellman,et al.  Activation of Lysosomal Function During Dendritic Cell Maturation , 2003, Science.

[52]  R. Misra,et al.  Gene targeting in the mouse , 2002, Endocrine.

[53]  P. Cosson,et al.  Separation and Characterization of Late Endosomal Membrane Domains* , 2002, The Journal of Biological Chemistry.

[54]  Wei Xu,et al.  aph-1 and pen-2 Are Required for Notch Pathway Signaling, γ-Secretase Cleavage of βAPP, and Presenilin Protein Accumulation , 2002 .

[55]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[56]  M. Owen,et al.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.

[57]  M. Rigoulet,et al.  Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* , 2000, The Journal of Biological Chemistry.

[58]  V. Shnyrov,et al.  Analysis of differential scanning calorimetry data for proteins. Criteria of validity of one-step mechanism of irreversible protein denaturation. , 1997, Biophysical chemistry.

[59]  F. Supek,et al.  A novel accessory subunit for vacuolar H(+)-ATPase from chromaffin granules. , 1994, The Journal of biological chemistry.

[60]  H Connor,et al.  Metformin kinetics in healthy subjects and in patients with diabetes mellitus. , 1981, British journal of clinical pharmacology.

[61]  Arne Skerra,et al.  The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins , 2007, Nature Protocols.